News
FDA approves 1st treatment for chronic lung disease
The FDA has approved Insmed’s brensocatib, the first treatment for non-cystic fibrosis bronchiectasis, a chronic and progressive lung disease affecting about 500,000 people in the U.S. The drug was approved for use in adults and children 12 and older and is a once-daily oral medication that targets neutrophilic inflammation,
The FDA stated that consumers should check their home for these affected products and throw away any cookware that can leach ...
Precigen's immunotherapy for a rare respiratory disease has become the first treatment to win U.S. regulatory approval for ...
Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved ...
16h
FDA sends warning to 5 sunscreen brands including Supergoop — why they could be pulled from shelves
The alert follows a wave of warning letters the agency sent to Supergoop!, Vacation Inc. and three other popular brands, accusing them of peddling whipped, mousse and foam sunscreens that flout ...
The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...
Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.
Popular sunscreen products that come in mousse form, such as Supergoop!'s body mousse, may not protect wearers from the sun's ...
2don MSN
More than 20 GOP attorneys general call on RFK Jr, FDA to reinstate safeguards for abortion drugs
More than 20 Republican attorneys general are demanding that the Trump administration reinstate safety protocols for the ...
Lead is toxic to people of any age or health status and higher exposure levels can lead to neurological changes ...
While the FDA is working on removing the pots from shelves, it has been unable to initiate a mass recall, the agency warned.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback